We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FIBK:NASDAQFirst Interstate BancSystem, Inc. Analysis

Data as of 2026-06-16 - not real-time

$36.77

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

First Interstate BancSystem (FIBK) is trading at $36.77, comfortably above its 20‑day SMA (35.57) and 50‑day SMA (35.07), with the 200‑day SMA (34.23) also below price, confirming a bullish trend. The RSI of 60.6 and a bullish MACD histogram (+0.16) further support momentum, though the stock sits near the technical resistance of $37.17, limiting immediate upside to roughly 0.6%. Valuation metrics show a trailing P/E of 12 versus the industry average of 17, suggesting the stock is priced below peers, while the DCF‑derived fair value of $35.27 is slightly under the current price, indicating a modest premium. Dividend yield remains attractive at 5.16% with a payout ratio of 61%, backed by robust cash reserves ($1.24 B) that exceed total debt ($0.85 B).
Fundamentally, revenue grew 3.6% YoY, operating margin stands at 35%, and ROE is 9.3%, reflecting solid profitability for a regional bank. However, the 30‑day volatility of 26% and a beta of ~1.1 point to heightened price swings, while decreasing volume hints at waning short‑term trader interest. The combination of strong balance sheet, sustainable dividend, and relative valuation discount makes the stock appealing for medium‑ to long‑term investors despite sector‑specific regulatory and interest‑rate sensitivities.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance limiting upside
  • Decreasing volume suggests weaker short‑term demand
  • High dividend yield provides cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to industry P/E
  • Strong cash position and manageable debt
  • Sustainable dividend supporting total return

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent profitability and modest revenue growth
  • Robust balance sheet with net cash surplus
  • Attractive dividend yield and payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth3.60%
Profit Margin30.01%
P/E Ratio12.0
ROE9.29%
ROA1.14%
P/B Ratio1.1
Op. Cash Flow$282.1M
Industry P/E17.0

Technical Analysis

TrendBullish
RSI60.6
Support$34.00
Resistance$37.17
MA 20$35.57
MA 50$35.07
MA 200$34.23
MACDBullish
VolumeDecreasing
Fear & Greed Index92.86

Valuation

Fair Value$35.27
Target Price$37.00
Upside/Downside0.63%
GradeFair
TypeValue
Dividend Yield5.16%

Risk Assessment

Beta1.10
Volatility26.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.